Focused on cellular health research, the company develops and commercializes nicotinamide riboside (NR), a form of vitamin B3 marketed as an NAD+ precursor used in dietary supplements and clinical research. Its Niagen ingredient and Tru Niagen consumer brand generate revenue through ingredient licen...
2 members of Congress have disclosed 2 trades in ChromaDex Diagnostics Inc (CDXC), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2020-04-02 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2015-04-02 | Chris Collins | sell | $250K – $500K |